Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

GenVec collaborates with LMIV on malaria vaccines

April 23, 2015

Inovio initiates phase I trial of HBV DNA vaccine INO-1800

April 22, 2015

Expedited development of lonafarnib with ritonavir for hepatitis D virus infection

April 21, 2015

An attenuated, gD-deleted vaccine provides 100% protection against herpes simplex virus

April 21, 2015

U.S. HHS patent covers anti-JC virus ASOs

April 20, 2015

Ventria Bioscience develops fusion protein as vaccine for Lyme disease

April 20, 2015

ID Pharma enters new agreement with National Institute of Infectious Diseases of Japan

April 20, 2015

Researchers identify highly potent dengue-neutralizing MAb

April 20, 2015

Ombitasvir/paritaprevir/ritonavir HCV combination granted priority review in Japan

April 17, 2015

Merck & Co. discloses novel HCV NS5A inhibitor

April 15, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...